• About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Terms & Conditions
Saturday, January 28, 2023
The Washington Mail
  • Home
  • World
  • Business
  • Tech
  • Entertainment
  • Health
  • Lifestyle
No Result
View All Result
The Washington Mail
No Result
View All Result

Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head

by Editorial Board
August 23, 2022
in Tech News
Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head


Building a leadership team with global and local experience and expertise to enable rapid execution across Company’s broad therapeutic strategy

DURHAM, N.C. and BEIJING, Aug. 22, 2022 /PRNewswire/ — Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced the appointments of Eleanor (Ellee) de Groot, Ph.D., as Chief Technology Officer and Aleksandar Skuban, M.D., as Central Nervous System (CNS) Diseases Therapy Area Head.

“Ellee and Aleksandar are both seasoned biotech leaders with impressive credentials and an entrepreneurial history of leading medicine development and manufacturing initiatives within their functional areas. We are excited to welcome them to the Brii Bio team as we continue to advance our pipeline of innovative drug candidates on behalf of patients facing significant health burdens around the world,” said Zhi Hong, Ph.D., Chairman and Chief Executive Officer of Brii Bio. “With experience spanning all phases in the making of medicines, Ellee is an important addition to our executive team as we execute against our broad therapeutic modalities. Likewise, Aleksandar’s deep expertise in CNS and mental health clinical development and patient care will be essential as we prioritize the advancement of our lead U.S. therapeutic programs in postpartum depression and major depressive and anxiety disorders.”

Eleanor (Ellee) de Groot, Ph.D., Chief Technology Officer

Dr. de Groot has more than two decades of experience leading a wide range of streamlined global operations across growing biotechnology companies, from early to late stage clinical development and commercial-scale manufacturing. Dr. de Groot held key leadership roles during her career with Alaunos Therapeutics, most recently serving as Executive Vice President of Operations where she oversaw the development of novel cell therapy programs and led clinical manufacturing, quality and process development. In addition, during her extended tenure at Helsinn Therapeutics, Dr. de Groot held multiple roles of increasing responsibility within CMC management where she directed preparations for drug product commercialization, including global regulatory engagement, technology transfers and collaborations with key business partners worldwide. Dr. de Groot holds both a Ph.D. and Master of Science degree in chemical engineering from Stanford University, a Bachelor of Science degree in chemical engineering from Massachusetts Institute of Technology (MIT) and a Master of Business Administration from Rice University.

“I believe Brii Bio’s diversified pipeline of promising therapeutic candidates shows great potential to address some of the biggest public health challenges of our time, and I’m eager to contribute my expertise to support ongoing product development and generate a sustainable long-term growth strategy within the Company,” said Ellee de Groot, Ph.D., Chief Technology Officer of Brii Bio.

Aleksandar Skuban, M.D., CNS Diseases Therapy Area Head

Dr. Skuban brings to Brii Bio more than 25 years of global pharmaceutical R&D experience with an extensive medical, scientific and business leadership track record of achievements, including leading more than 30 studies across therapeutic areas from early stage proof of concept through positive regulatory outcomes, with a focus in CNS diseases. Previously, Dr. Skuban served as SVP of Clinical Development at Better Therapeutics, where he shaped research strategy to enable rapid development of new indications for prescription digital therapeutics. Prior to that, he served as an Executive Medical Director leading clinical development within Alexion’s emerging ophthalmology therapeutic area. At Otsuka Pharmaceuticals, Dr. Skuban’s tenure included roles overseeing various clinical portfolios, notably guiding to FDA approval for Brexpiprazole (REXULTI) for major depressive disorder and schizophrenia. Dr. Skuban also held a number of clinical development director roles at Merck and Sanofi-Aventis. He earned a Doctor of Medicine degree from Semmelweis University of Medicine, Budapest, Hungary and attended the School of Medicine at the University of Novi Sad, Novi Sad, Yugoslavia (Serbia).

“I am inspired by the meaningful patient-centric approach that Brii Bio has cultivated in the earliest stages of clinical planning. I look forward to incorporating unique patient insights into Brii’s CNS programs to ensure our investigational treatments are well-positioned for the future of mental healthcare and grounded in the fundamental understanding of patients’ preferences and needs,” said Aleksandar Skuban, M.D., CNS Diseases Therapy Area Head of Brii Bio.

About Brii Bio

Brii Biosciences Limited (“Brii Bio”, stock code: 2137.HK) is a biotechnology company based in China and the United States committed to advancing therapies for significant infectious diseases, such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases, which have significant public health burdens in China and worldwide. For more information, visit www.briibio.com.

SOURCE Brii Biosciences Limited

Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head



Source link

Tags: AleksandarAppointsareaBiosciencesBriiCentralchiefdiseasesEleanorGrootNervousOfficerSkubanSystemTechnologyTherapy
Editorial Board

Editorial Board

Get the latest news and updates on World News, Business, Tech, Entertainment and more.

Related Posts

Microchip Technology logo

Microchip Technology (MCHP) Set to Announce Earnings on Thursday

by Editorial Board
January 26, 2023
0

Microchip Technology (NASDAQ:MCHP - Get Rating) will release its earnings data after the market closes on Thursday, February 2nd. Analysts...

Cal Poly and Stanford project awarded grant for student-led technology research

Cal Poly and Stanford project awarded grant for student-led technology research

by Editorial Board
January 24, 2023
0

SAN LUIS OBISPO, Calif. – A collaborative project on ethical and social impacts of artificial intelligence between California Polytechnic State...

WhatsApp

WhatsApp testing a new feature that lets users share high quality images

by Editorial Board
January 22, 2023
0

WhatsApp developers seem to be constantly working on bringing new features to Meta’s instant messaging platform. A recent report by...

Next Post
I Like Beer the Podcast hosts raise a glass with Seek Beer Company owner Dave Ohmer, center, at BeerX Craft Beer and Music Festival at Waterfront Park in San Diego. Photo by Jeff Spanier

Celebrating San Diego brews, music and lifestyle at BeerX

Popular Stories

  • DYOR Paving the Path to Digital Supremacy in Web 3.0 and NFT Industries

    DYOR Paving the Path to Digital Supremacy in Web 3.0 and NFT Industries

    0 shares
    Share 0 Tweet 0
  • Top Three Fruity Slots

    0 shares
    Share 0 Tweet 0
  • Congratulations on Lenercom ESS Won the iF design award 2022!

    0 shares
    Share 0 Tweet 0
  • Entrepreneur Davide De Vries redefines online sales through his distinctive mentorship programs.

    0 shares
    Share 0 Tweet 0
  • morph: The Web3 Brand That Bridges The Gap Between Real and Virtual Worlds Through Digital Innovation

    0 shares
    Share 0 Tweet 0

Recommended

Seaside Scenes: Three birthdays celebrated at downtown island party | Lifestyle

Seaside Scenes: Three birthdays celebrated at downtown island party | Lifestyle

September 17, 2022
The Suttle Lodge welcomes Nick Delffs | lifestyle | bendbulletin.com - The Bulletin

The Suttle Lodge welcomes Nick Delffs | lifestyle | bendbulletin.com – The Bulletin

July 20, 2022
Hong Kong drops COVID curbs for arrivals, scraps health app | Business and Economy

Hong Kong drops COVID curbs for arrivals, scraps health app | Business and Economy

December 13, 2022
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Terms & Conditions

© 2022 The Washington Mail. All Rights Reserved.

No Result
View All Result
  • Home
  • World
  • Business
  • Tech
  • Entertainment
  • Health
  • Lifestyle

© 2022 The Washington Mail. All Rights Reserved.